Poly(lactic-co-glycolic acid) (PLGA) is a polymer commonly used as a scaffold in tissue engineering because it exhibits biodegradable and biocompatible properties. PLGA allows for the encapsulation of growth factors, such as insulin-like growth factor I (IGF-I), which has been shown to stimulate the synthesis of cartilage. The components of cartilage that are used as markers for cartilage growth are proteoglycan and type-II collagen, which can be measured and monitored using a variety of assays. The objective was to determine if there is an effect of temperature on IGF-I after being encapsulated in a PGLA scaffold and it’s ability to increase cell proliferation and therefore cartilage growth. In this study an IGF-I solution was incubated at various temperatures in order to find the range that IGF-I can withstand. To evaluate the effectiveness of IGF-I, this solution was added onto cells and monitored for DNA production in comparison to the control, which contained no IGF-I. It was found that IGF-I could withstand up to 50°C and still maintain bioactivity. Afterwards, the IGF-I was encapsulated into PLGA microspheres and fabricated into scaffolds. These scaffolds were then placed in a buffer solution, which was changed every 2-3 days. The released supernatant was then analyzed for IGF-I content to determine the rate of release and was also added onto cells to verify that the IGF bioactivity was not lost due to scaffold fabrication. As a final evaluation, bone marrow cells were seeded onto the IGF-I-loaded scaffolds to evaluate the effect of the added IGF, which showed an increase in glycosaminoglycan and DNA content at 3 and 4 weeks compared to the blank scaffolds, concluding that IGF-I cannot only withstand increased temperatures but that it does have a positive effect on cartilage growth.
Poly(lactic-co-glycolic acid) (PLGA) is a polymer commonly used as a scaffold in tissue engineering because it exhibits biodegradable and biocompatible properties. PLGA allows for the encapsulation of growth factors, such as insulin-like growth factor I (IGF-I), which has been shown to stimulate the synthesis of cartilage. The components of cartilage that are used as markers for cartilage growth are proteoglycan and type-II collagen, which can be measured and monitored using a variety of assays. The objective was to determine if there is an effect of temperature on IGF-I after being encapsulated in a PGLA scaffold and it’s ability to increase cell proliferation and therefore cartilage growth. In this study an IGF-I solution was incubated at various temperatures in order to find the range that IGF-I can withstand. To evaluate the effectiveness of IGF-I, this solution was added onto cells and monitored for DNA production in comparison to the control, which contained no IGF-I. It was found that IGF-I could withstand up to 50°C and still maintain bioactivity. Afterwards, the IGF-I was encapsulated into PLGA microspheres and fabricated into scaffolds. These scaffolds were then placed in a buffer solution, which was changed every 2-3 days. The released supernatant was then analyzed for IGF-I content to determine the rate of release and was also added onto cells to verify that the IGF bioactivity was not lost due to scaffold fabrication. As a final evaluation, bone marrow cells were seeded onto the IGF-I-loaded scaffolds to evaluate the effect of the added IGF, which showed an increase in glycosaminoglycan and DNA content at 3 and 4 weeks compared to the blank scaffolds, concluding that IGF-I cannot only withstand increased temperatures but that it does have a positive effect on cartilage growth.
Further posting is closed as the event has ended.
Presented by IGERT.org.
Funded by the National Science Foundation.
Copyright 2023 TERC.
Presented by IGERT.org.
Funded by the National Science Foundation.
Copyright 2023 TERC.
Judges and Presenters may log in to read queries and replies.